WORKING WITH US
Harnessing nearly two decades of experience, The Chase Group, Inc. offers standard-setting professional recruitment services in the Life Sciences industry. Because we work exclusively in the substantive areas of global pharmaceuticals, biotechnology, academic medicine and research, non-profits, animal health, diagnostics, medical devices and healthcare communications, our executive recruiters are focused strictly on identifying, targeting and securing the highest quality candidates skilled for these unique markets. By maintaining an extensive network of strategic contacts specific to the Life Sciences industry, The Chase Group can deliver responsive, timely and cost-effective recruitment solutions that meet our clients’ and candidates’ specialized needs.
FINDING A CANDIDATE
Dedication, keen industry insight, individualized service and a competitive spirit unite in The Chase Group’s proprietary approach to recruitment, enabling us to effectively and efficiently secure the high-caliber candidates our clients require.
SECURING A NEW POSITION
Much more than just an executive search firm directory, The Chase Group offers individualized services for both clients and candidates, ensuring that skills, qualifications and personalities are a precise match. For us and for our candidates, each placement signifies more than a job—it may reflect the beginning of an enduring career or the next critical step in one’s professional evolution.
"Find a job you love and never work another day in your life..."
Feb 18, 2015
Esperion Therapeutics Partners with The Chase Group
Esperion Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of clinical research and development programs and medical affairs implemented by Esperion. Potential candidates should contact Joyce...
Jan 12, 2015
Ipsen VP Neurology Franchise Secured
The Chase Group is proud to announce they recently completed a search for Vice President, Neurology Franchise for Ipsen US. Donald Pearl has been hired to spearhead leadership of sales and marketing for current and future products.
Jan 12, 2015
RRD International Retains The Chase Group
RRD International has retained The Chase Group to secure a Chief Development Officer to direct and manage the day-to-day activities of all RRD International product development staff and functions. Potential candidates should contact Joyce at 913.663.3100.
Jan 12, 2015
Acorda Therapeutics and The Chase Group Partner Once Again
Acorda Therapeutics has retained The Chase Group to secure a Medical Director of Clinical and Medical Affairs to join their rapidly expanding clinical development team. For more information, please contact Mary at 913.663.3100.
Jan 12, 2015
The Chase Group Fills Key Leadership Role for Marinus Pharmaceuticals
The Chase Group is proud to announce the completion of a search for the Chief Medical Officer for Marinus Pharmaceuticals with the hiring of Albena Patroneva, MD. Dr. Patroneva will oversee the overall direction, planning, execution and interpretation of medical affairs, regulatory affairs, and...
Oct 24, 2014
The Chase Group Fills Key Leadership Role for Cambridge BioMarketing
The Chase Group is proud to announce the completion of a search for Creative Director/Copy for Cambridge BioMarketing. This key role drives strategy and execution for the agency’s work with rare and orphan drug clients.
Oct 23, 2014
Ipsen Biosciences Retains The Chase Group for Neuroendocrine Position
Ipsen Biosciences has retained The Chase Group to secure a Director of Molecular and Cellular Endocrinology who will lead the company’s research programs to devise therapeutic strategies for endocrine diseases with unmet medical needs. Potential candidates should contact Joyce Tucker at...
Sep 19, 2014
Marinus Pharmaceuticals Retains The Chase Group
Marinus Pharmaceuticals has retained The Chase Group to secure a Chief Medical Officer to lead the overall direction, planning, execution and interpretation of medical affairs, regulatory affairs and clinical research programs implemented by Marinus. Potential candidates should contact Joyce Tucker...
Aug 28, 2014
TCG Continues Successful Collaboration with Isis Pharmaceuticals
The Chase Group announces the recruitment of Dr. Fred Derosier as Executive Director, Clinical Development. Dr. Derosier is excited to join such a dynamic organization, and TCG appreciates the opportunity to work together with Isis to expand their team of top-performing clinical development...
Aug 28, 2014
Durata Therapeutics and The Chase Group Partner Once Again
Durata Therapeutics has retained The Chase Group to secure two Executive Directors of Clinical and Medical Affairs to join their rapidly expanding clinical development team. For more information, please contact Joyce at 913.663.3100.